A-A-51572A
11 June 1987
SUPERSEDING
A-A-0051572 (DM)
14 July 1986
COMMERCIAL ITEM DESCRIPTION
THIABENDAZOLE TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient Characteristics:
Shall be pleasantly flavored, palatable, chewable, scored tablets.
Shall contain the equivalent of 500 mg of Thiabendazole per tablet, within the applicable assay limits for the tablets.
Materials used in manufacture shall be of pharmaceutical grade.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Package (PG). One package containing 36 individually sealed, strip packaged foil-wrapped tablets, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business